JD Finley Net Worth & Insider Trades

JD Finley - Chief Financial Officer, Palisade Bio, Inc

As of May 2, 2022

What is JD Finley's Net Worth?

The current estimated net worth of Palisade Bio, Inc's Chief Financial Officer, JD Finley, is estimated to be about $14.01K . JD Finley owns about 48,218 units of Palisade Bio, Inc common stock. In the last year at Palisade Bio, Inc, JD Finley has sold an estimated value of $0 worth.

What is JD Finley's Past Insider Trading?

JD Finley's largest purchase order was 10,000 units , worth over $26.47K on August 30, 2021. In total, JD Finley has made about 7 transactions over a year of their time at Palisade Bio, Inc. JD Finley usually trades in February, with the busiest year in 2022. The most recent transaction was a purchase order of 7,500 units , worth over $8.17K on March 25, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is JD Finley's' Mailing Address?

  • Mailing address is C/o Seneca Biopharma, Inc. 20271 Goldenrod Lane Germantown MD 20876 MD

Palisade Bio, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Kenneth Carter, PhD, 2019 $395,000 $20,000 - $425,409 - - - $840,409
Kenneth Carter, PhD, 2018 - - - - - - - -
Richard J. Daly, 2019 - - - - - - - -
Richard J. Daly, 2018 $239,167 $146,370 - - - - - $385,537
James Scully, 2019 - - - - - - - -
James Scully, 2018 $208,725 - - $191,310 - - - $400,035
Matthew Kalnik, PhD 2019 - - - - - - $358,758 $358,758
Matthew Kalnik, PhD 2018 - - - - - - - -
Dane Saglio 2019 - - - - - - $84,750 $84,750
Dane Saglio 2018 - - - - - - - -
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1357459/000117184320004540/def14a_062320.htm

What are Palisade Bio, Inc's Past Insider Trades?

Palisade Bio, Inc's most recent insider trade came on March 31, 2022 by Michael Dawson who bought 15,000 units worth $17.09K . In the last year, insiders at Palisade Bio, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are JD Finley, Chief Financial Officer,  Thomas Hallam, Chief Executive Officer,  and Michael Dawson, Chief Medical Officer .

PALISADE BIO, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1